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INTRODUCTION: Inﬂammatory myoﬁbroblastic tumors (IMFTs) are neoplastic lesions that are either
benign or have low-grade malignancy potential. Although the etiopathogenesis is not entirely clear,
many factors play a role in their development, including trauma, autoimmune disorders, and infectious
and inﬂammatoryprocesses.However, IMFTs causedbyActinomyces spp. infection are rare,with a limited
number of cases reported in the literature.
PRESENTATION OF CASE: A 30-year-old woman was admitted to our clinic with abdominal pain and
a palpable abdominal mass. Contrast-enhanced computed tomography revealed a tumoral lesion
(11×10×7 cm) in the right colon. A right hemicolectomy and ileocolic anastomosis were performed,
during which almost complete obstruction of the lumen by the 7.5×7.0×5.0 cm tumor was observed.
Histopathology and immunohistochemical ﬁndings revealed that the tumor was consistent with an
IMFT that developed from an Actinomyces infection. The patient was then placed on amoxicillin and
doxycycline therapy.
CONCLUSION: This case demonstrates that the development of IMFT secondary to actinomycosis is dif-
ﬁcult to predict in the preoperative period. Once an exact diagnosis is conﬁrmed by histopathologic
examination, affected patients should receive prolonged antibiotherapy.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Inﬂammatory myoﬁbroblastic tumors (IMFTs) are pseudosar-
comatous inﬂammatory lesions that typically show a benign
behavioral pattern [1]. However, these tumors have the poten-
tial to locally recur and invade neighboring tissues, and though
rare, they can also metastasize to distant sites. These lesions can
be found in almost all organs and tissues of human body, though
they most commonly occur in the lungs or within the abdominal
cavity [1]. The most common extrapulmonary sites are the omen-
tum and mesentery, but lesions can also be found in the stomach,
liver, gallbladder, spleen, pancreas, and colon [1–3]. Despite being
seen in almost all age groups, IMFTs most commonly occur in chil-
dren and young adults, and are more frequent in women than in
men. Whether IMFTs are an inﬂammatory lesion or a true neo-
plasm remains controversial. Many factors have been implicated
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in their etiopathogenesis, including the presence of autoimmune
disorders, bacterial or viral infections, trauma, and undergoing a
surgical operation. This report describes a rare case of a colonic
IMFT that developed secondary to an Actinomyces infection.
2. Presentation of case
A 30-year-old woman was referred to our outpatient clinic
with abdominal pain and a palpable abdominal mass. She had
fatigue and malaise concurrent with a mass in the lower-right
quadrant of her abdomen that had been progressively growing
for six months. She stated that she had given birth to three chil-
dren and undergone a Caesarean section one year ago, and had
not used an intrauterine device (IUD) for birth control. Physical
examination revealed a 10×10 cm mobile mass in the lower-right
quadrant of her abdomen. Blood testswere as follows: hemoglobin,
10.5 g/dL (normal: 12.5–16.0 g/dL); hematocrit, 33.8% (normal:
37–47%); mean corpuscular (MC) volume, 62 L (normal: 78–100L);
MC hemoglobin, 19pg (normal: 27–33pg); MC hemoglobin con-
centration, 31.1 g/dL (normal: 32.5–35.2 g/dL); ferritin, 52ng/mL
(normal: 30–400ng/mL); total iron-binding capacity, 256g/dL
http://dx.doi.org/10.1016/j.ijscr.2015.02.014
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Contrast-enhanced abdominal tomography.Markedmural thickeningwas observed in the terminal ileumand colon segment, andneighboringmesentery andpericolic
fatty tissue had a heterogeneous appearance. An 11×10×7 cm isodense mass was seen in the ascending colon.
Fig. 2. Histopathology of the tumor. Hematoxylin and eosin staining revealed (A) bland fusiform elements arranged in fascicules, with (B) lymphocytes, plasma cells, and
eosinophils, indicative of an inﬂammatory myoﬁbroblastic tumor. (C) The bland fusiform elements of the tumor contained Actinomyces (basophilic clusters of bacteria with
a peripheral, more eosinophilic zone of radiating ﬁlaments surrounded by acute inﬂammation) (A: 100× ; B: 200× ; C: 100× ).
(normal: 155–300g/dL); vitamin B12, 370pg/mL (normal:
191–663pg/mL); folic acid, 6.8ng/mL (normal: 3.1–17.5ng/mL);
white blood cell count, 11,900L (normal: 4100–11,200/L);
platelet count, 468,000L (normal: 150–400,000L); C-reactive
protein, 71mg/dL (normal: 0–5mg/dL). Other biochemical blood
tests and urinalysis were normal. An abdominal plain ﬁlm was also
normal, but abdominal ultrasonography showed conglomerated
bowel loops in the pericecal region in the lower-right quadrant.
Contrast-enhanced abdominal computed tomography revealed
marked mural thickening in the terminal ileum and colon seg-
ment, a heterogeneous appearance of the neighboring mesentery
and pericolic fatty tissue, and an isodense mass (11×10×7 cm)
in the ascending colon (Fig. 1). These ﬁndings suggested plas-
troned appendicitis, colonic tumor, or granulomatous disease, and
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Fig. 3. Immunohistochemical analysis. The tumor cells were immunopositive for
vimentin (100× ).
the decision was made to proceed with surgery. A laparotomy
was performed via a midline incision, and exploration revealed
a 10×10 cm mass lesion that was 10 cm distal to ileocecal valve.
Severe edema and lymphadenopathies in the mesenteric tissues
surrounding the mass were observed. The mass was considered
malignant, and a standard right hemicolectomy and ileocolic anas-
tomosis were performed. Macroscopic examination of the tumor
specimen showed a 7.5×7.0×5.0 cm tumoral lesion that nearly
completely obstructed the bowel lumen. Histopathologic ﬁndings
were consistent with an IMFT, which included foci of Actinomyces
(Fig. 2). The tumor cells were immunopositive for vimentin (Fig. 3)
and desmin, and negative for CD34 and S-100. No tumor tissue was
found in any of the 30 lymph nodes that were also biopsied. These
ﬁndings indicate that the tumor was an inﬂammatory pseudotu-
mor that developed secondary to an Actinomyces infection. The
patient was discharged on the sixth postoperative and placed on
amoxicillin and doxycycline therapy for an additional six months.
3. Discussion
IMFTs are typically benign inﬂammatory lesions of soft tissue,
though they can potentially invade neighboring tissues, appear-
ing both clinically and radiologically as malign tumors, and are
thus referred to as pseudotumors. Because of their potential for
invasion, local recurrence, and distant organ metastasis, IMFTs are
deﬁned by theWorldHealth Organization as neoplasmswith inter-
mediate biological potential [1]. The histopathologic properties
of these lesions have led to a variety of designations, including
inﬂammatory pseudotumors, plasma cell granulomas, inﬂamma-
tory myoﬁbrohistiocytic proliferation, histiocytoma, xanthoma,
ﬁbroxanthoma, and xanthomatous pseudotumors [1].
IMFTs occur in patients with rheumatoid arthritis, systemic
lupus erythematosus, and Sjögren’s syndrome, suggesting that
autoimmunity plays a role in their development [1]. Recent cyto-
genetic studies have shown a relationship between IMFTs and
mutations in the gene encoding anaplastic lymphoma kinase [1].
However, a signiﬁcantmajority of patientswith IMFT havemalaise,
loss of appetite, anemia, fever, and weight loss, suggesting a possi-
ble role of infectious diseases in the etiology [1]. Infectious agents
implicated in the emergence of IMFTs include the Epstein–Barr
virus, Campylobacter jejuni, Mycobacterium avium-intracellulare,
Escherichia coli, Pseudomonas veronii, Pasteurella haemolytica, Bac-
teroides corrodens, Coxiella burnetii, and Actinomyces israelii [1].
A. israelii is a gram-positive anaerobic or microaerophilic ﬁl-
amentous bacterium that is a component of the normal ﬂora
within the oropharynx, bronchial tree, upper gastrointestinal sys-
tem, and female genitalia [2–7]. This bacterium only invades the
mucosal barrier and adjacent tissues when injury occurs [2,7],
which induces an inﬂammatory response and facilitates pseu-
dotumor development [6]. Actinomyces inﬁltration is the cause
of actinomycosis, deﬁned as a chronic, progressive, suppurative
disease characterized bymultiple abscesses, drained sinuses, abun-
dant granulation tissue, and dense ﬁbrous tissue [2,5,7] Abdominal
actinomycosis constitutes 20% of all actinomycosis cases [2]. It
mostly involves the ileocecal region and right colon, but can also
affect the retroperitoneum, perianal region, urinary bladder, liver,
spleen, and sometime the stomach [5,6]. The most common pre-
disposing factor for abdominal actinomycosis is prolonged IUD use
[2,3]. Otherpredisposing factors include appendicitis, diverticulitis,
intestinal perforation, peptic ulcer perforation, cholecystectomy,
thyphoid fever, amebic dysentery, trauma, and hemorrhagic pan-
creatitis [2,7]. Although the patient in the present case had no
history of IUD use, she had prolonged discharge that terminated
spontaneously from the right corner of the surgical incision from
the caesarean section.
Abdominal actinomycosis can manifest as a variety of symp-
toms, including nonspeciﬁc abdominal pain, malaise, appetite loss,
fever, weight loss, abdominal mass, postoperative foul smelly dis-
charge, and signs of intestinal obstruction [1]. Laboratory tests
generally indicate an elevated erythrocyte sedimentation rate, and
leukocytosis, neutrophilia, and elevated C-reactive protein levels,
as demonstrated in the present case. However, it is not possible
to diagnose abdominopelvic actinomycosis solely by clinical and
biochemical parameters, as these mimic chronic infectious disor-
ders or malignant abdominal tumors. Abdominal actinomycosis
has no speciﬁc radiological feature [2], and can appear to invade
neighboring tissues as malignant tumors do, with mass-like dense
granulation tissue and ﬁbrosis.
Similarly, it is difﬁcult to differentiate abdominal
actinomycosis-induced IMFTs from IMFTs secondary to other
causes, which perhaps can only be distinguished by the frequent
appearance of abscesses, sinuses, or ﬁstulas. Nevertheless, the
presence of yellowish-brown sulfur granules and/or branching
gram-positive non-acid resistant bacilli in tumoral lesions can
be a diagnostic indicator. In addition, bacteria may proliferate in
anaerobic culture [8]. Newer molecular methods, such as poly-
merase chain reaction, are increasingly being used for diagnosis
of Actinomyces sp. However, histopathologic evaluation should
ultimately be performed for diagnosis/differential diagnosis of a
tumoral component, as pseudotumors can contain varying ratios
of spindle cells, myoﬁbroblasts, and inﬂammatory cell inﬁltrates
such as plasma cells, lymphocytes, and histiocytes. Immunohis-
tochemical staining, such as for smooth-muscle actin, desmin,
activin receptor-like kinase-1, creatine, cyclooxygenase-2, and
vascular endothelial growth factor, are most commonly used for
differential diagnosis of the disease.
The management of abdominopelvic actinomycosis is depen-
dent on both the extent of the disease and the condition of the
patient [9]. Surgical removal of the tumoral lesion with resection
or drainage, supplemented with long-term antibiotic therapy is
recommended, [9,10] such as with parenteral penicillin G [2,9] fol-
lowed by peroral penicillin V or amoxicillin for up to 12 months
[2,9,10]. Tetracycline, erythromycin, clindamycin can be given in
those with penicillin allergy [2]. Ultrasonography or computed
tomography are used to check treatment efﬁciency and recur-
rences.Ourexperienceshave indicated thatmedical therapy should
be pursued at least until symptoms and inﬂammatory signs sub-
side, as actinomycosis is a resistant infection and can lead to severe
ﬁbrosis and granulation tissue.
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In conclusion, this is the ﬁrst report of actinomycosis-induced
IMFT developing in the right colon. The development of IMFTs
secondary to actinomycosis is difﬁcult to preoperatively predict,
and should be conﬁrmed by histopathologic examination. Affected
patients should receive prolonged antibiotherapy once the diagno-
sis is conﬁrmed.
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